GRI Bio, Inc. (GRI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 35K 70K 105K Q4 '20: 100K Q1 '21: 0 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '22: 0 Q4 '20 Q1 '21 Q2 '21 Q3 '21 Q4 '21 Q1 '22

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-15M -10M -5M 0 5M 10M 15M Q4 '20: -4.8M Q1 '21: -6.2M Q2 '21: -7.4M Q3 '21: -7.6M Q4 '21: -9.3M Q1 '22: -9.3M Q2 '22: -7.2M Q3 '22: -6.1M Q4 '23: -11.4M Q1 '24: -12.3M Q2 '24: -8.6M Q3 '24: -8.3M Q4 '24: -8.2M Q1 '25: -9.4M Q2 '25: -10M Q3 '25: -11.3M Q4 '25: -12M Q1 '26: -10.9M Q2 '26: -9.7M Q4 '20 Q3 '21 Q2 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-15M -10M -5M 0 5M 10M 15M Q3 '21: -7.7M Q4 '21: -9.3M Q1 '22: -7M Q2 '22: -5M Q3 '22: -4M Q4 '22: -3.2M Q1 '23: -5.1M Q2 '23: -11.5M Q3 '23: -13.3M Q4 '23: -13M Q1 '24: -12.8M Q2 '24: -8.3M Q3 '24: -8.3M Q4 '24: -8.2M Q1 '25: -9.4M Q2 '25: -10M Q3 '25: -11.2M Q4 '25: -12M Q1 '26: -10.9M Q2 '26: -9.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-15M -10M -5M 0 5M 10M 15M Q3 '21: -7.5M Q4 '21: -8.3M Q1 '22: -7.7M Q2 '22: -3M Q3 '22: -1.8M Q4 '22: -1.1M Q1 '23: 626K Q2 '23: -3.1M Q3 '23: -4.3M Q4 '23: -9M Q1 '24: -10.6M Q2 '24: -11.2M Q3 '24: -12.2M Q4 '24: -8.6M Q1 '25: -8.1M Q2 '25: -9.2M Q3 '25: -9.2M Q4 '25: -10.2M Q1 '26: -12.1M Q2 '26: -10.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q4 '20: -3.7M Q4 '20

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 2.5M 5M 7.5M Q2 '20: 4.5M Q3 '20: 4.5M Q1 '21: 5.7M Q2 '21: 6.8M Q3 '21: 6.8M Q1 '22: 227.1K Q2 '22: 851.4K Q3 '22: 896.1K Q1 '23: 143K Q2 '23: 28.2K Q3 '23: 32.5K Q1 '24: 18.7K Q2 '24: 36.4K Q3 '24: 185.9K Q1 '25: 18.8K Q2 '25: 78.8K Q3 '25: 2.6M Q1 '26: 1.2M Q2 '26: 1.8M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6000.00 -4000.00 -2000.00 0.00 2000.00 4000.00 6000.00 Q4 '20: -1.07 Q1 '21: -1.27 Q2 '21: -1.36 Q3 '21: -1.31 Q4 '21: -1.44 Q1 '23: -39.67 Q2 '23: -278.69 Q3 '23: -344.08 Q4 '23: -4888.94 Q1 '24: -4974.95 Q2 '24: -4797.43 Q3 '24: -4743.07 Q4 '24: -1642.32 Q1 '25: -1703.57 Q2 '25: -1678.44 Q3 '25: -1668.30 Q4 '25: -121.80 Q1 '26: 38.89 Q2 '26: 74.70 Q4 '20 Q3 '21 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.